Dr. Kristine Chapman and Core’s Dr. Judy Illes writes about the recent ads for stem-cell therapies and its implications to patients suffering from peripheral neuropathy. Click the title to read more.
Most older adults are online, and many of them are using the internet to search for health-related information. But how easy to understand is the information they are finding, and who wrote it? Dr. Julie Robillard’s new research, published this week in the journal Gerontechnology (paywall) presents troubling insight… Click the title to read more.
Since 2007, the National Core for Neuroethics has been an international leader in biomedical research ethics under the direction of Dr. Judy Illes, Canada Research Chair in Neuroethics. For more than a decade, Dr. Illes has been influential in shaping … Click the title to read more.
The Governor General Julie Payette met with new Order of Canada & Order of British Columbia recipients, including Core’s Dr. Judy Illes. Photo by: MCpl Vincent Carbonneau, Rideau Hall https://www.gg.ca/gallery.aspx?ID=11787
CBC Radio’s BC Almanac speaks with Prof. Jennifer A. Chandler on medical aid in dying in their March 13, 2018 episode. Listen to the interview starting at the 25:44 mark.
Globe and Mail’s article on smartphone use quotes Core’s Dr. Peter B. Reiner. Click the title to read more.
CBC Radio’s The Current with Anna Maria Tremonti discusses the ethics of new (invasive) technologies that appear to improve memory with Core’s Dr. Peter B. Reiner. Listen to the conversation below (start at 31:20 mark).
Neuroethics Canada’s Dr. Judy Illes explains why she is participating in the #SupportTheReport campaign! Watch the video here: For more information on #SupportTheReport, visit: https://supportthereport.ca/
The 15th anniversary of what is widely viewed as the first neuroethics conference, “Neuroethics: Mapping the Field” was celebrated in 2017. The meeting was held in San Francisco, organized by the University of California and Stanford, and sponsored by the Dana Foundation. Click the title to read more.
Wherein lies the promise versus the hype, when discussing the latest in brain-related research and neurotechnology? Have we considered patient justice? Is actionable data actually available? Click the title to read more.